The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Personalized neoadjuvant strategy in ER positive and HER2 negative breast cancer to increase BCS rate (PLATO): A prospective, multicenter, phase II clinical trial.
 
Wonshik Han
Leadership - DCGen
Stock and Other Ownership Interests - DCGen
 
Eunhye Kang
No Relationships to Disclose
 
Hong-Kyu Kim
Stock and Other Ownership Interests - Berits Inc.
Research Funding - GeneCker
 
Han-Byoel Lee
Leadership - DCGen
Stock and Other Ownership Interests - DCGen
Honoraria - Alvogen Korea; Boryung; Roche; Takeda
Consulting or Advisory Role - Boryung; Lilly; Need, Inc. (Inst); Novartis
Research Funding - Devicor Medical Products
Patents, Royalties, Other Intellectual Property - Patent for an NGS-based breast cancer multigene prognostic panel
Travel, Accommodations, Expenses - DCGen
 
Jisun KIM
Stock and Other Ownership Interests - Genopeaks
Research Funding - Genopeaks (Inst)
 
Hee-Chul Shin
Leadership - DCGen
Stock and Other Ownership Interests - DCGen
 
Hyun-Ah Kim
No Relationships to Disclose
 
Eun-Kyu Kim
No Relationships to Disclose
 
Byung Ho Son
No Relationships to Disclose